FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Mayne Pharma Bromfenac Ophthalmic Solution 0 Recall

Bromfenac Ophthalmic Solution 0

Mayne Pharma Usa · Greenville, NC

Risk level
Class II
Reported by FDA
Jan 27, 2016
Recall ID
D-0585-2016
Check your lot numberHow we source this data

Summary

Mayne Pharma recalled Bromfenac Ophthalmic Solution 0 starting Jan 5, 2016. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0585-2016 on Jan 27, 2016. Reason: Lack of Assurance of Sterility: Failed preservative effectiveness test. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility: Failed preservative effectiveness test

Product description

Bromfenac Ophthalmic Solution 0.09%, a) 2.5 mL bottles (NDC 0378-7110-35) and b) 5 mL bottles (NDC 00378-7109-35), Rx only, Mylan Pharmaceuticals, Inc., Morgantown, WV 26505

Lot numbers, UPCs & expiration codes

a) Lot numbers: 0378-7110-35 AD4819, Exp. Date: 08-2016; 0378-7110-35 AC7894, Exp. Date: 05-2016; 0378-7110-35 AD2527, Exp. Date: 06-2016; 0378-7110-35 AC6330, Exp. Date: 05-2016; 0378-7110-35 AC2330, Exp. Date: 04-2016 and b) Lot numbers: 0378-7109-35 AD4515, Exp. Date: 04-2016 and 0378-7109-35 AC2328, Exp. Date: 01-2016.

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0585-2016
Classification
Class II
Status
Terminated
Recall initiated
Jan 5, 2016
FDA report date
Jan 27, 2016
Quantity
a) 52034 bottles and b) 22074 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Mayne Pharma Usa

Original FDA data

Every field from FDA enforcement report D-0585-2016, exactly as published.

Show all FDA fields
City
Greenville
State
NC
Status
Terminated
Country
United States
Event ID
73072
Address
1240 Sugg Pkwy
Code information
a) Lot numbers: 0378-7110-35 AD4819, Exp. Date: 08-2016; 0378-7110-35 AC7894, Exp. Date: 05-2016; 0378-7110-35 AD2527, Exp. Date: 06-2016; 0378-7110-35 AC6330, Exp. Date: 05-2016; 0378-7110-35 AC2330, Exp. Date: 04-2016 and b) Lot numbers: 0378-7109-35 AD4515, Exp. Date: 04-2016 and 0378-7109-35 AC2328, Exp. Date: 01-2016.
Postal code
27834-9006
Report date
Jan 27, 2016
Product type
Drugs
Recall number
D-0585-2016
Classification
Class II
Recalling firm
Mayne Pharma Usa
Product quantity
a) 52034 bottles and b) 22074 bottles
Termination date
Jan 13, 2017
Reason for recall
Lack of Assurance of Sterility: Failed preservative effectiveness test
Voluntary / mandated
Voluntary: Firm initiated
Product description
Bromfenac Ophthalmic Solution 0.09%, a) 2.5 mL bottles (NDC 0378-7110-35) and b) 5 mL bottles (NDC 00378-7109-35), Rx only, Mylan Pharmaceuticals, Inc., Morgantown, WV 26505
Distribution pattern
Nationwide
Recall initiation date
Jan 5, 2016
Initial firm notification
Letter
Center classification date
Jan 20, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0585-2016, published Jan 27, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls